Dr. Buffington on MRI Fusion for Prostate Cancer

Philip J. Buffington, MD
Published Online: Tuesday, Feb 14, 2017



Philip J. Buffington, MD, chief medical officer, The Urology Group, discusses MRI fusion-guided biopsy in patients with prostate cancer.

MRI fusion is done in many groups for the second biopsy for patients with prostate cancer, Buffington explains. A patient receiving MRI fusion is either on active surveillance with known prostate cancer or had a negative biopsy in the past but their prostate-specific antigen (PSA) is still rising.

The MRI is not so much for screening but helps target an area that may have been missed on a prior biopsy. A patient receives an MRI and if there is a concerning area the physicians take those images and fuse it with the images from the ultrasound to better target the area and biopsy it, says Buffington.
 


Philip J. Buffington, MD, chief medical officer, The Urology Group, discusses MRI fusion-guided biopsy in patients with prostate cancer.

MRI fusion is done in many groups for the second biopsy for patients with prostate cancer, Buffington explains. A patient receiving MRI fusion is either on active surveillance with known prostate cancer or had a negative biopsy in the past but their prostate-specific antigen (PSA) is still rising.

The MRI is not so much for screening but helps target an area that may have been missed on a prior biopsy. A patient receives an MRI and if there is a concerning area the physicians take those images and fuse it with the images from the ultrasound to better target the area and biopsy it, says Buffington.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Update from Chicago: Advances in the Treatment of Genitourinary CancersJul 28, 20171.5
Clinical Vignette Series: 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®Feb 28, 20182.0
Publication Bottom Border
Border Publication
$emailPop$